Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Martin Avenue Pharmacy, Inc.
483
•Martin Avenue Pharmacy, Inc.•July 21, 2014

Martin Avenue Pharmacy, Inc. – FDA 483, Jul 21, 2014

Record Details

During a field examination, a black particle was observed in a vial of sterile injectable human drug product Bi-Mix. The facility's procedures for preventing microbiological contamination of sterile drug products lack adequate validation of the sterilization process. Deficient aseptic practices were observed during the production of Acetylcysteine (Preservative Free) 20% Inhalation Solution, including the use of non-sterile items, improper spraying techniques, and repeated touching of open vials and caps. Sterile syringes used for filling were not labeled as non-pyrogenic, and sterilizing equipment was not tested after use. The firm does not conduct media fills or have evidence that sterilizing equipment for containers, closures, and drug products is effective or validated.

Time limits for production phases are not established, with observations of open bulk product solution left exposed and unsupported hold times for unsterilized stock solutions. Batch production records lack complete information, specifically regarding visual inspections of sterile products.

Control systems to prevent contamination during aseptic processing are deficient. Sanitization practices were inadequate, with improper use of sanitizers, lack of sanitization of HEPA filter guards, and insufficient sanitization of equipment. Environmental monitoring for microbial contamination or particles in ISO 5 hoods and the Class 10,000 clean room is not conducted during production, and personnel are not monitored for microbial contamination. Dynamic smoke pattern testing has not been conducted. The Class 10,000 clean room has a sink with municipal tap water and a

Company
Martin Avenue Pharmacy, Inc.
Inspection date
July 21, 2014
Product type
Devices
Office
Chicago District Office
Person
  • Russell K. Riley (Investigator)
View Company Profile

ID · 1e962ddc-a8a3-4c78-aab3-d87f249d0cca

Violation Codes10
21 CFR 21021 CFR 21121 CFR 211.113(b)FD&C Act 801(a)(3)21 CFR 331(c)21 CFR 211.84(d)(2)21 CFR 211.100(b)21 CFR 211.188(b)21 CFR 211.67(b)21 CFR 211.167(a)

Full citation text and observation details available on the Dashboard.

Other documents for Martin Avenue Pharmacy, Inc.
  • WARNING_LETTER - 2014-07-21July 21, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Martin Avenue Pharmacy, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.